Skip to main content

Table 1 Characteristics of CRC patients and healthy controls used in the study- and validation-cohorts.

From: Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer

Descriptions

Study-Cohort

Validation-Cohort

Healthy Controls

Non-Metastatic CRC

Metastatic CRC

Healthy Controls

Non-Metastatic CRC

Metastatic CRC

Numbers

10

10

10

15

14

16

Gender

      

Female

4

4

4

15

5

11

Male

6

6

6

0

9

5

Median age (range)

51 (40–66)

58 (43–78)

59 (41–72)

46 (43–55)

69 (51–85)

61 (40–82)

Stages of cancer

      

I

-

2

-

-

10

-

II

-

8

-

-

4

-

III

-

-

4

-

-

7

IV

-

-

6

-

-

9

Back to article page

Clinical Proteomics

ISSN: 1559-0275